First-in-human robotic percutaneous coronary intervention by the ROSES robotic system: a case report

Ciro Indolfi; Alberto Polimeni; Salvatore De Rosa; Guido Danieli

doi:10.1093/ehjcr/ytad506

First-in-human robotic percutaneous coronary intervention by the ROSES robotic system: a case report

Eur Heart J Case Rep. 2023 Oct 13;7(10):ytad506. doi: 10.1093/ehjcr/ytad506. eCollection 2023 Oct.

Authors

Ciro Indolfi^{1

2}, Alberto Polimeni¹, Salvatore De Rosa¹, Guido Danieli³

Affiliations

¹ Division of Cardiology, Department of Medical and Surgical Sciences, Magna Graecia University, Viale Europa snc, 88100 Catanzaro, Italy.
² Mediterranea Cardiocentro, Via Orazio 2, 80122 Naples, Italy.
³ Calabrian High Tech-CHT S.r.l., Rende (CS), Italy.

Abstract

Background: Robotic-assisted percutaneous coronary intervention (R-PCI) is increasingly gaining acceptance owing to several advantages.

Case summary: Here, we report the first-in-human R-PCI performed with RObotic System for Endovascular Surgery (ROSES), an innovative robotic system designed to perform transcatheter angioplasty. We have reported a case of severe proximal posterolateral (PL) branch disease of the right coronary artery managed with R-PCI.

Discussion: In this early clinical experience, the use of the ROSES robotic system seems to be safe and effective. However, this report still represents an early feasibility study, and the use of this technology in more challenging anatomies including the presence of severe tortuosity, severe calcification, or interventions requiring multiple wires and balloons needs to be further studied. A larger, prospective, multicentre pivotal clinical trial designed to test the ROSES robotic angioplasty system in a larger number of patients is currently ongoing.

Keywords: Angioplasty; Case report; Percutaneous coronary intervention; Robotics.

Publication types

Case Reports